The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations
Open accessAbstract
INTRODUCTION: The 2018 Global Meningococcal Initiative (GMI) meeting focused on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and protection strategies worldwide, with emphasis on emerging antibiotic resistance and protection of high-risk populations. The GMI is comprised of a multidisciplinary group of scientists and clinicians representing institutions from several continents. AREAS COVERED: Given that the incidence and prevalence of IMD continually varies both geographically and temporally, and surveillance systems differ worldwide, the true burden of IMD remains unknown. Genomic alterations may increase the epidemic potential of meningococcal strains. Vaccination and (to a lesser extent) antimicrobial prophylaxis are the mainstays of IMD prevention. Experiences from across the globe advocate the use of conjugate vaccines, with promising evidence growing for protein vaccines. Multivalent vaccines can broaden protection against IMD. Application of protection strategies to high-risk groups, including individuals with asplenia, complement deficiencies and human immunodeficiency virus, laboratory workers, persons receiving eculizumab, and men who have sex with men, as well as attendees at mass gatherings, may prevent outbreaks. There was, however, evidence that reduced susceptibility to antibiotics was increasing worldwide. EXPERT COMMENTARY: The current GMI global recommendations were reinforced, with several other global initiatives underway to support IMD protection and prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parikh, S. R., Andrews, N. J., Beebeejaun, K., Campbell, H., Ribeiro, S., Ward, C., White, J. M., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31921-3 · Cited by 275
Self-citationBrooks, R., Woods, C. W., Benjamin, Jr., & Rosenstein, N. E. (2006) · Clinical Infectious Diseases · doi:10.1086/504804 · Cited by 124
Folaranmi, T. A., Kretz, C. B., Kamiya, H., MacNeil, J. R., Whaley, M. J., Blain, A., Antwi, M., Dorsinville, M., Pacilli, M., Smith, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix438 · Cited by 75 · cited 8×
“Currently, the prevailing factor for vaccination recommendations is the country-specific incidence of respective Nm serogroups across age groups; however, the application of protection strategies to other high-risk groups, such as individuals with asplenia, complement deficiencies, and HIV, persons receiving eculizuma…”
BackgroundInfluentialSelf-citationCeyhan, M., Gürler, N., Ozsurekci, Y., Keser, M., Aycan, A. E., Gurbuz, V., Salman, N., Camcioglu, Y., Dinleyici, E. C., Ozkan, S., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29678 · Cited by 60
Self-citation
Research works printed but not linked: 159
- 10.1086/322587 · DOI
- 10.1016/j.vaccine.2011.12.062 · DOI · Paper page
- 10.1038/nrmicro3093 · DOI · Paper page
- 10.1016/j.vaccine.2011.02.058 · DOI
- 10.1016/j.jinf.2018.01.007 · DOI
- 10.1016/j.jinf.2017.04.007 · DOI
- 10.4103/2249-4863.184616 · DOI
- 10.1128/JCM.00445-18 · DOI
- Centers for Disease Control and Prevention [Internet], Meeting of the Advisory Committee on Immunization Practices (ACIP) February 2017 Agenda
- Reported IMD incidence in Canada by serogroup, 1995–2015 [slides] 2018
- 10.1016/j.vaccine.2014.10.072 · doi:10.1016/j.vaccine.2014.10.072
- Koroleva I, Korolev MA, Beloshitsky GV, 2017, [Meningococcal infection and purulent bacterial meningitis in the Russian Federation in 2016: analytical review]
- The Institute of Environmental Science and Research Ltd. [Internet], Notifiable diseases in New Zealand annual report 2016
- National Institute for Communicable Diseases [Internet], GERMS South Africa annual report 2016
- Centers for Disease Control R.O.C (Taiwan) [Internet], Meningococcal Meningitis
- 10.1016/j.vaccine.2016.06.018 · doi:10.1016/j.vaccine.2016.06.018
- 10.1093/jpids/piu027 · DOI
- 10.1093/cid/civ597 · DOI
- 10.7189/jogh.06.020409 · doi:10.7189/jogh.06.020409
- 10.1016/S1473-3099(17)30301-8 · DOI · Paper page
- 10.1016/S1473-3099(15)00217-0 · DOI
- 10.1016/j.vaccine.2006.11.018 · DOI
- 10.26719/2016.22.5.343 · doi:10.26719/2016.22.5.343
- 10.1016/j.vaccine.2017.03.027 · DOI
- Matosova SV, 2014, Epidemiologiya i Infektsionnyie Bolezni, 2, 52
- Pan American Health Organization [Internet], 2018, Informe regional de SIREVA II, 2014. Datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos bacterianos
- 10.1080/21645515.2017.1415682 · DOI
- (CBHI). TCBoHI [Internet], National health profile 2017 India
- 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518 · DOI
- 10.3201/eid2210.160468 · DOI
- National Institute of Infectious Diseases Japan [Internet], Invasive meningococcal infection, April 2013–October 2017, Japan
- 10.1371/journal.pone.0019717 · DOI
- 10.1016/j.jinf.2015.07.007 · DOI · Paper page
- 10.3201/eid1909.130160 · doi:10.3201/eid1909.130160
- International Pathogenic Neisseria Conference [Internet], 20th International Pathogenic Neisseria Conference Abstracts Manchester
- 10.1177/2051013616650158 · doi:10.1177/2051013616650158
- 10.1080/21645515.2015.1051276 · DOI
- 10.1128/JCM.01409-17 · DOI
- 10.1016/S2468-2667(17)30157-3 · doi:10.1016/s2468-2667(17)30157-3
- Jafri RZ, 2013, Popul Health Metr, 11, 1
- 10.1093/cid/ciu057 · DOI
- 10.1371/journal.pone.0058065 · doi:10.1371/journal.pone.0058065
- Smaoui H, 2011, Archs Inst Pasteur Tunis, 88, 35
- 10.1080/21645515.2016.1268304 · DOI
- 10.1016/S0140-6736(08)60350-5 · doi:10.1016/s0140-6736(08)60350-5
- 10.1016/j.jinf.2017.10.015 · doi:10.1016/j.jinf.2017.10.015
- 10.2807/1560-7917.ES.2016.21.45.30395 · DOI
- 10.1038/srep41126 · DOI
- 10.3201/eid2308.170259 · doi:10.3201/eid2308.170259
- 10.2807/1560-7917.ES.2017.22.28.30574 · doi:10.2807/1560-7917.es.2017.22.28.30574
- 10.1001/jama.1995.03520290042027 · DOI · Paper page
- Krizova P, 1995, Cent Eur J Public Health, 3, 189
- 10.1136/bmj.324.7341.809 · DOI
- 10.1186/s12864-018-4560-x · DOI
- 10.1073/pnas.1620971114 · doi:10.1073/pnas.1620971114
- 10.1093/gbe/evw122 · DOI
- 10.1016/j.jinf.2017.05.015 · DOI
- 10.1016/j.ijid.2018.01.019 · DOI
- 10.1093/cid/cix215 · doi:10.1093/cid/cix215
- 10.1371/journal.pone.0154047 · DOI
- New Jersey Department of Health [Internet], Meningococcal invasive disease FAQ
- 10.1056/NEJMoa1514866 · DOI
- 10.3201/eid2305.161870 · doi:10.3201/eid2305.161870
- Centers for Disease Control and Prevention [Internet], Meeting of the Advisory Comittee on Immunization Practices (ACIP) October 2016 Agenda
- 10.1016/S1473-3099(16)30253-5 · DOI
- 10.15585/mmwr.mm6642a5 · DOI
- 10.1016/S1473-3099(18)30476-6 · doi:10.1016/s1473-3099(18)30476-6
- 10.1073/pnas.1802298115 · DOI
- 10.3346/jkms.2003.18.2.163 · doi:10.3346/jkms.2003.18.2.163
- 10.1016/S0140-6736(06)68141-5 · doi:10.1016/s0140-6736(06)68141-5
- 10.3201/eid2106.140687 · doi:10.3201/eid2106.140687
- 10.1038/nri2494 · DOI · Paper page
- 10.1086/527401 · DOI · Paper page
- 10.1586/erv.10.3 · DOI
- Granoff DM, 2012, Vaccines, 388
- Menjugate® (Meningococcal group C-CRM197 conjugate vaccine), 2013, Product monograph, novartis vaccines and diagnostics S.r.l.
- Meningitec®(Meningococcal Serogroup C Conjugate Vaccine), 2011, Product information
- Menitorix® (Haemophilus influenzae type b Polyribose ribitol phosphate and serogroup C Meningococcal polysaccharide conjugate vaccine [Hib-MenC]), 2016, Product information
- MenAfriVac® (Meningococcal A conjugate vaccine), 2011, Package insert
- Menactra® (Meningococcal [Groups A C, Y and W–135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), 2016, Highlights of prescribing information
- Menveo® (Meningococcal [Groups A C, Y and W–135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine), 2013, Highlights of prescribing information
- Nimenrix® (Meningococcal polysaccharide serogroups A CNovartis Vaccines and Diagnostics S.r.l., W–135 and Y conjugate vaccine), 2014, Consumer medicine information
- Mencevax ACWY® (Serogroups A C, W–135 and Y polysaccharide meningococcal vaccine), 2015, Product information
- Menomune® (A/C/Y/W–135 meningococcal polysaccharide vaccine), 2016, Highlights of prescribing information
- NeisVac-C® (Meningococcal Group C-TT Conjugate Vaccine), 2015, Consumer information
- 10.3201/eid2307.170236 · DOI
- Govern d’Andorra [Internet], Pla de vacunacions
- Ministero della Salute [Internet], Piano nazionale prevenzione vaccinale PNPV 2017–2019
- HSE Immunisation [Internet], Immunisation guidelines for ireland: meningococcal infection
- Ministry of Health of The Republic of Lithuania [Internet], Official: children in Lithuania will be vaccinated against type B meningococcus
- 10.1016/S0264-410X(01)00299-7 · DOI · Paper page
- Public Health England, 2018, [slides] Any Impact on serogroup W?
- 10.3201/eid2306.161768 · doi:10.3201/eid2306.161768
- 10.1093/cid/cis892 · DOI · Paper page
- 10.1016/S0140-6736(13)61612-8 · DOI · Paper page
- Kristiansen PA, 2014, BMC Infect Dis, 14, 1
- 10.3201/eid2101.140256 · DOI
- 10.1093/infdis/126.5.514 · DOI · Paper page
- 10.4161/hv.24129 · DOI · Paper page
- 10.1016/j.vaccine.2017.05.065 · doi:10.1016/j.vaccine.2017.05.065
- 10.1126/science.287.5459.1809 · DOI · Paper page
- 10.1016/S0264-410X(00)00554-5 · DOI
- 10.1126/science.287.5459.1816 · DOI · Paper page
- 10.1016/S0140-6736(14)60842-4 · DOI · Paper page
- 10.1016/S2352-4642(18)30103-2 · DOI
- 10.1136/archdischild-2017-312941 · DOI
- 10.3201/eid2202.150369 · DOI
- Borrow R, 2018, 2018; MRF Meningitis Symposium
- 10.1080/21645515.2018.1438028 · doi:10.1080/21645515.2018.1438028
- Ochoa-Azze R, 2016, Vacci Monitor, 25, 43
- Pérez Rodriguez A, 1999, Mem Inst Oswaldo Cruz, 94, 440
- Sotolongo FS, 2007, MEDICC Rev, 9, 16, 10.37757/MR2007V9.N1.6 · DOI
- Echeverry Uribe M, 1995, Biol Oficina Sanit Panam, 118, 295
- 10.1097/00006454-200111000-00010 · doi:10.1097/00006454-200111000-00010
- Camaraza M, 2004, Rev Cubana Med Trop, 56, 26
- 10.1016/j.meegid.2010.02.002 · doi:10.1016/j.meegid.2010.02.002
- 10.1128/JCM.01653-09 · doi:10.1128/jcm.01653-09
- 10.1111/j.1365-2958.1989.tb01802.x · DOI
- 10.1111/j.1600-0463.2012.02903.x · DOI
- 10.1371/journal.ppat.1003528 · DOI
- 10.1016/S0140-6736(17)31449-6 · DOI · Paper page
- Minesterio de Salud Pública (MINSAP) Cuba [Internet], National office of statistics data
- 10.1093/ofid/ofx180.002 · doi:10.1093/ofid/ofx180.002
- 10.1542/peds.2016-2084 · DOI
- 10.1016/j.vaccine.2017.03.002 · DOI
- 10.4161/hv.2.2.2611 · DOI
- 10.1093/cid/civ508 · DOI
- 10.1016/j.vaccine.2016.11.076 · doi:10.1016/j.vaccine.2016.11.076
- 10.1128/CVI.00549-10 · doi:10.1128/cvi.00549-10
- Mueller J, 2013, Poster presented at: Meningitis Research Foundation Conference
- Yaro S, 2017, Poster presented at: Meningococcal Research Foundation Conference
- 10.1074/jbc.M304607200 · doi:10.1074/jbc.m304607200
- 10.1093/jac/dkw400 · doi:10.1093/jac/dkw400
- 10.1128/AAC.00412-07 · DOI
- 10.1128/AAC.00315-10 · DOI
- 10.1128/AAC.02184-12 · DOI
- 10.3201/eid1310.060820 · doi:10.3201/eid1310.060820
- 10.1099/jmm.0.078600-0 · DOI
- 10.1371/journal.pmed.1001838 · doi:10.1371/journal.pmed.1001838
- Centers for Disease Control and Prevention [Internet], 2018, Active bacterial core surveillance (ABCs) surveillance reports
- 10.1128/IAI.72.1.332-337.2004 · DOI
- 10.1093/cid/ciy141 · DOI
- Centers for Disease Control and Prevention [Internet], Meeting of the Advisory Committee on Immunization Practices (ACIP) summary report: rationale and proposed recommendations for revaccination of persons at increased risk for meningococcal disease (presentation summary)
- 10.1086/515075 · DOI · Paper page
- 10.1097/00006454-199310000-00002 · DOI
- 10.15585/mmwr.mm6543a3 · DOI
- 10.15585/mmwr.mm6627e1 · DOI · Paper page
- 10.1128/JCM.43.9.4811-4814.2005 · doi:10.1128/jcm.43.9.4811-4814.2005
- 10.1016/j.vaccine.2018.06.027 · DOI
- 10.3201/eid2305.161713 · DOI
- 10.1016/j.ijid.2016.04.007 · doi:10.1016/j.ijid.2016.04.007
- 10.1016/S0140-6736(87)91056-7 · DOI
- 10.3201/eid0906.020565 · doi:10.3201/eid0906.020565
- 10.26719/2013.19.4.389 · doi:10.26719/2013.19.4.389
- 10.1016/j.tmaid.2009.05.003 · DOI
- Folkehelseinstituttet [Internet], Ungdom og vaksine mot smittsom hjernehinnebetennelse
- 10.5365/wpsar.2016.7.3.007 · doi:10.5365/wpsar.2016.7.3.007
- Hachisu Y, 2017, Poster presented at: ID Week
- 10.1016/j.ijid.2016.03.007 · doi:10.1016/j.ijid.2016.03.007
Cited by
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C. J., van der Linden, M. P. G., Amin-Chowdhury, Z., Bennett, D. E., Borrow, R., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00077-7 · Cited by 546
Self-citationCommunity-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Parikh, S. R., Campbell, H., Bettinger, J. A., Harrison, L. H., Marshall, H. S., Martinon-Torres, F., Safadi, M. A., Shao, Z., Zhu, B., von Gottberg, A., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.079 · Cited by 274
Self-citationVaccination of immune compromised children—an overview for physicians
Pittet, L. F., & Posfay-Barbe, K. M. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-03997-1 · Cited by 31
Metadata
- Authors
- Acevedo, R., Bai, X., Borrow, R., Caugant, D. A., Carlos, J., Ceyhan, M., Christensen, H., Climent, Y., De Wals, P., Dinleyici, E. C., Echaniz-Aviles, G., Hakawi, A., Kamiya, H., Karachaliou, A., Lucidarme, J., Meiring, S., Mironov, K., Sáfadi, M. A. P., Shao, Z., Smith, V., Steffen, R., Stenmark, B., Taha, M.-K., Trotter, C., Vázquez, J. A., & Zhu, B.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2018-12-27
- Volume
- 18
- Issue
- 1
- Pages
- 15-30
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2905534193
- Cited by
- 191
- References
- 4
- FWCI
- 14.69
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-09)
- Open access
- hybrid
- Funders
- supported by Sanofi Pasteur (N/A)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. https://app.cochat.ai/papers/10.1080/14760584.2019.1557520
- The paper
- Acevedo, R., Bai, X., Borrow, R., Caugant, D. A., Carlos, J., Ceyhan, M., Christensen, H., Climent, Y., De Wals, P., Dinleyici, E. C., Echaniz-Aviles, G., Hakawi, A., Kamiya, H., Karachaliou, A., Lucidarme, J., Meiring, S., Mironov, K., Sáfadi, M. A. P., Shao, Z., . . . Zhu, B. (2019). The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Review of Vaccines. https://doi.org/10.1080/14760584.2019.1557520
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.